A Rock and a Hard Place: Chiseling Away at the Multiple Mechanisms of Aortic Stenosis
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
onrheumatic aortic stenosis has assumed center stage in contemporary cardiology because of the aging of the population and the prodigious advances in percutaneous approaches to its treatment.Many refer to this disease dismissively as "degenerative".That term implies an inevitable, ineluctably progressive, and inherent process that defies slowing or regressing.Use of the term degenerative cloaks our ignorance regarding mechanisms, much as do the designations idiopathic cardiomyopathy or essential hypertension.Yet, in step with the remarkable advances in addressing the mechanical aspects of aortic stenosis, researchers continue to stride toward better mechanistic understanding of the pathophysiology of this condition.Rather than "degenerative" aortic stenosis, we advocate use of the terms fibrocalcific or sclerocalcific aortic valve disease: nomenclature that captures the hardening of the valve tissue and its mineralization.We now recognize a number of active biological mechanisms that pave the pathway to alterations in the structure and function of the aortic valve (Figure 1). A Rock and a Hard Place Chiseling Away at the Multiple Mechanisms of Aortic Stenosis
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus
Scirica, B. M., Bhatt, D. L., Braunwald, E., Steg, P. G., Davidson, J., Hirshberg, B., Ohman, P., Frederich, R., Wiviott, S. D., Hoffman, E. B., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1307684 · Cited by 3,470 · cited 1×
“indicate the need to evaluate DPP-4 inhibitors in this regard, and examine whether they have adverse effects on bone metabolism or promote heart failure, the latter of particular concern in the CAVD population.(15) The recent advances in the mechanistic understanding of CAVD such as the provocative results with DPP-4…”
BackgroundIntensive Lipid Lowering with Simvastatin and Ezetimibe in Aortic Stenosis
Rossebø, A. B., Pedersen, T. R., Boman, K., Brudi, P., Chambers, J. B., Egstrup, K., Gerdts, E., Gohlke-Bärwolf, C., Holme, I., Kesäniemi, Y. A., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0804602 · Cited by 1,644 · cited 1×
“SEAS (the Simvastatin and Ezetimibe in Aortic Stenosis trial) and other clinical studies showed a lack of the therapeutic benefits of statins in CAVD and further emphasized the need to focus on valve-specific therapeutic targets.(14) The studies of Song et al.”
ResultMutations in NOTCH1 cause aortic valve disease
Garg, V., Muth, A. N., Ransom, J. F., Schluterman, M. K., Barnes, R., King, I. N., Grossfeld, P. D., & Srivastava, D. (2005) · Nature · doi:10.1038/nature03940 · Cited by 1,509
Genesis and growth of extracellular-vesicle-derived microcalcification in atherosclerotic plaques
Hutcheson, J. D., Goettsch, C., Bertazzo, S., Maldonado, N., Ruiz, J. L., Goh, W., Yabusaki, K., Faits, T., Bouten, C., Franck, G., et al. (2016) · Nature Materials · doi:10.1038/nmat4519 · Cited by 419
Self-citationDweck, M. R., Jones, C., Joshi, N. V., Fletcher, A. M., Richardson, H., White, A., Marsden, M., Pessotto, R., Clark, J. C., Wallace, W. A., et al. (2012) · Circulation · doi:10.1161/circulationaha.111.051052 · Cited by 337 · cited 1×
“Indeed, chronic inflammation contributes to valve calcification in mice, a phenomenon now established by Fluoride and fluorodeoxyglucose imaging in humans.(5)”
BackgroundMathieu, P., Bossé, Y., Huggins, G. S., Corte, A. D., Pibarot, P., Michelena, H. I., Limongelli, G., Boulanger, M., Evangelista, A., Bédard, E., et al. (2015) · The Journal of Pathology: Clinical Research · doi:10.1002/cjp2.21 · Cited by 76
Cited by
Calcific aortic valve disease: from molecular and cellular mechanisms to medical therapy
Kraler, S., Blaser, M. C., Aikawa, E., Camici, G. G., & Lüscher, T. F. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehab757 · Cited by 281
ApoC-III is a novel inducer of calcification in human aortic valves
Schlotter, F., de Freitas, R. C. C., Rogers, M. A., Blaser, M. C., Wu, P.-J., Higashi, H., Halu, A., Iqbal, F., Andraski, A. B., Rodia, C. N., et al. (2021) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.015700 · Cited by 49
AVCAPIR: A Novel Procalcific PIWI-Interacting RNA in Calcific Aortic Valve Disease
Han, D., Zhou, T., Li, L., Ma, Y., Chen, S., Yang, C., Ma, N., Song, M., Zhang, S., Wu, J., et al. (2024) · Circulation · doi:10.1161/circulationaha.123.065213 · Cited by 38
Non-Canonical TERT Activity Initiates Osteogenesis in Calcific Aortic Valve Disease
Cuevas, R. A., Hortells, L., Chu, C. C., Wong, R., Crane, A., Boufford, C. K., Regan, C., Moorhead, W. J., Bashline, M. J., Parwal, A., et al. (2025) · Circulation Research · doi:10.1161/circresaha.122.321889 · Cited by 11
(2022) · doi:10.1101/2022.08.23.504425 · Cited by 11
Future prospects in the tissue engineering of heart valves: a focus on the role of stem cells
Albert, B. J., & Butcher, J. T. (2023) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2023.2214313 · Cited by 8
Mueller, K. A. L., Langnau, C., Harm, T., Sigle, M., Mott, K., Droppa, M., Borst, O., Rohlfing, A.-K., Gekeler, S., Günter, M., et al. (2024) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.124.321000 · Cited by 7
Metadata
- Authors
- Aikawa, E., & Libby, P.
- Venue
- Circulation
- Published
- 2017-05-16
- Volume
- 135
- Issue
- 20
- Pages
- 1951-1955
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2616745707
- Cited by
- 68
- References
- 6
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.